Market Overview

Benzinga's Top Upgrades, Downgrades For January 4, 2017

Share:
Related CRL
4 Medical Stocks That Could Be Big Winners Next Week
A Peek Into The Markets: U.S. Stock Futures Edge Lower Ahead Of Yellen Speech
Related HFC
Benzinga's Top Upgrades, Downgrades For May 4, 2017
Earnings Scheduled For May 3, 2017

Top Upgrades

  • Analysts at Evercore ISI Group upgraded Charles River Laboratories Intl. Inc (NYSE: CRL) from Hold to Buy. Charles River shares rose 0.45 percent to close at $76.53 on Tuesday.
  • Deutsche Bank upgraded HollyFrontier Corp (NYSE: HFC) from Hold to Buy. HollyFrontier shares rose 2.47 percent to close at $33.57 on Tuesday.
  • Baird upgraded Aecom (NYSE: ACM) from Neutral to Outperform. AECOM shares rose 1.3 percent to $37.48 in pre-market trading.
  • Analysts at FBR Capital upgraded Abercrombie & Fitch Co. (NYSE: ANF) from Underperform to Market Perform. Abercrombie & Fitch shares rose 1.07 percent to $12.24 in pre-market trading.
  • Piper Jaffray upgraded Hologic, Inc. (NASDAQ: HOLX) from Neutral to Overweight. Hologic shares rose 0.10 percent to close at $40.16 on Tuesday.
  • Analysts at Goldman Sachs upgraded ON Semiconductor Corp (NASDAQ: ON) from Neutral to Buy. ON Semiconductor shares gained 2.92 percent to $13.05 in pre-market trading.
  • Loop Capital upgraded Canadian Pacific Railway Limited (USA) (NYSE: CP) from Hold to Buy. Canadian Pacific Railway shares fell 0.94 percent to close at $141.43 on Tuesday.
  • Goldman Sachs upgraded State Street Corp (NYSE: STT) from Neutral to Buy. State Street shares rose 1.97 percent to close at $79.25 on Tuesday.
  • Analysts at Barclays upgraded Agilent Technologies Inc (NYSE: A) from Equal-Weight to Overweight. Agilent shares rose 0.71 percent to $46.82 in pre-market trading.
  • Analysts at Bank of America upgraded Altria Group Inc (NYSE: MO) from Neutral to Buy.. Altria Group shares rose 1 percent to $68.30 in pre-market trading.


Top Downgrades

  • Goldman Sachs downgraded BlackRock, Inc. (NYSE: BLK) from Buy to Neutral. BlackRock shares fell 0.40 percent to $384.89 in pre-market trading.
  • Stifel Nicolaus downgraded Anthem Inc (NYSE: ANTM) from Buy to Hold. Anthem shares fell 0.37 percent to close at $143.24 on Tuesday.
  • Analysts at Cowen & Co. downgraded JetBlue Airways Corporation (NASDAQ: JBLU) from Outperform to Market Perform. JetBlue shares fell 0.31 percent to $22.32 in pre-market trading.
  • Deutsche Bank downgraded Noble Energy, Inc. (NYSE: NBL) from Buy to Hold. Noble Energy shares rose 0.97 percent to close at $38.43 on Tuesday.
  • Credit Suisse downgraded Baker Hughes Incorporated (NYSE: BHI) from Outperform to Neutral. Baker Hughes shares rose 0.09 percent to close at $65.03 on Tuesday.
  • Analysts at Evercore ISI Group downgraded Intuitive Surgical, Inc. (NASDAQ: ISRG) from Buy to Hold. Intuitive Surgical shares fell 0.59 percent to $638.00 in pre-market trading.
  • Goldman Sachs downgraded Microsemi Corporation (NASDAQ: MSCC) from Buy to Neutral. Microsemi shares rose 1.13 percent to close at $54.58 on Tuesday.
  • Analysts at Imperial Capital downgraded Zebra Technologies Corp. (NASDAQ: ZBRA) from Outperform to In-Line. Zebra Technologies shares rose 0.57 percent to close at $86.25 on Tuesday.
  • DA Davidson downgraded J & J Snack Foods Corp (NASDAQ: JJSF) from Buy to Neutral. J&J Snack shares fell 0.47 percent to close at $132.80 on Tuesday.
  • Bank of America downgraded Philip Morris International Inc. (NYSE: PM) from Buy to Neutral. Philip Morris shares fell 0.73 percent to $90.56 in pre-market trading.


Top Initiations

  • Analysts at UBS initiated coverage on Athene Holding Ltd (NYSE: ATH) with a Neutral rating. The price target for Athene Holding is set to $52. Athene Holding shares closed at $47.82 on Tuesday.
  • Analysts at Leerink Swann initiated coverage on Achaogen Inc (NASDAQ: AKAO) with an Outperform rating. The price target for Achaogen is set to $21. Achaogen shares closed at $13.00 on Tuesday.
  • Analysts at Craig-Hallum initiated coverage on Fusion Telecommunications Int'l, Inc. (NASDAQ: FSNN) with a Buy rating. The price target for Fusion Telecommunications is set to $3. Fusion Telecommunications shares closed at $1.45 on Tuesday.
  • Analysts at Rodman & Renshaw initiated coverage of Ritter Pharmaceuticals Inc (NASDAQ: RTTR) with a Buy rating. The price target for Ritter Pharmaceuticals is set to $7. Ritter Pharmaceuticals shares closed at $2.89 on Tuesday.
  • Analysts at Roth Capital initiated coverage on Kite Pharma Inc (NASDAQ: KITE) with a Buy rating. The price target for Kite Pharma is set to $68. Kite Pharma shares closed at $45.95 on Tuesday.
  • Analysts at Canaccord Genuity initiated coverage on Teladoc Inc (NYSE: TDOC) with a Buy rating. The price target for Teladoc is set to $24. Teladoc shares closed at $16.50 on Tuesday.
  • Analysts at JPMorgan initiated coverage on Global Blood Therapeutics Inc (NASDAQ: GBT) with an Overweight rating. The price target for Global Blood Therapeutics is set to $25. Global Blood Therapeutics shares closed at $14.30 on Tuesday.

Latest Ratings for CRL

DateFirmActionFromTo
Jan 2017Evercore ISI GroupUpgradesHoldBuy
Dec 2016Goldman SachsUpgradesSellNeutral
Nov 2016BarclaysUpgradesUnderweightEqual-Weight

View More Analyst Ratings for CRL
View the Latest Analyst Ratings

Posted-In: Downgrades Initiations top upgradesUpgrades Downgrades Initiation Analyst Ratings

 

Related Articles (A + ACM)

View Comments and Join the Discussion!